发明名称 |
STRATIFICATION OF PATIENT POPULATIONS HAVING OR SUSPECTED OF HAVING RHEUMATOID ARTHRITIS |
摘要 |
The present disclosure is directed to screening, diagnosing and treating patients having, or suspected of having, rheumatoid arthritis. Levels of glucose-6-phophate isomerase or antibodies to glucose-6-phophate isomerase are assayed in test subjects or populations to determine susceptibility to, or existence of, an antibody mediated form of rheumatoid arthritis in such test subjects or populations. The results of the assays provide guidelines for therapeutic intervention with complement inhibiting agents. |
申请公布号 |
WO03081206(A3) |
申请公布日期 |
2004.08.19 |
申请号 |
WO2003US08226 |
申请日期 |
2003.03.17 |
申请人 |
ALEXION PHARMACEUTICALS, INC.;ROTHER, RUSSELL, P. |
发明人 |
ROTHER, RUSSELL, P. |
分类号 |
C12Q1/533;G01N33/53;G01N33/564;G01N33/573 |
主分类号 |
C12Q1/533 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|